Posted On: 09/12/2014 12:18:01 PM
Post# of 9146
Re: rayludwiczak #342
You make a great observation about the share manipulation. As the company expands its revenues (right now from sales of the flat pack and BNP products to a number of companies) there will be no need for the company to rely in any way on PIPE deals.
As frustrating as this situation is, once NanoLogix is revenue self-sustaining the "game" is over for the manipulators. Then the N-Assay revenues will kick in and then a number of the "longs" will go "tooth and nail" after the people doing the manipulation.
The operating costs obviously had to increase with the hiring of a VP for Marketing but that was an absolutely essential step up[ for the company. You all know the rule-"You have to spend $$ to mke $$." I believe that NanoLogix has increased its market penetration with the flatpacks and BNPs and that the growth will be steady and provide an operating revenue base.
The point is that there is a disconnect between the share price and the projected value of the company. I see the situation as one in which the manipulators have built a dam to inhibit the upward "flow" of the share price. But the dam is actually quite flimsy and will not be able to hold as the sales of product increase steadily and then grow dramatically with the N-Assay panels starting with the neonatal markets. The dam will collapse, share prices will rise significantly and the "bad guys" will receive "visits" by serious people.
As frustrating as this situation is, once NanoLogix is revenue self-sustaining the "game" is over for the manipulators. Then the N-Assay revenues will kick in and then a number of the "longs" will go "tooth and nail" after the people doing the manipulation.
The operating costs obviously had to increase with the hiring of a VP for Marketing but that was an absolutely essential step up[ for the company. You all know the rule-"You have to spend $$ to mke $$." I believe that NanoLogix has increased its market penetration with the flatpacks and BNPs and that the growth will be steady and provide an operating revenue base.
The point is that there is a disconnect between the share price and the projected value of the company. I see the situation as one in which the manipulators have built a dam to inhibit the upward "flow" of the share price. But the dam is actually quite flimsy and will not be able to hold as the sales of product increase steadily and then grow dramatically with the N-Assay panels starting with the neonatal markets. The dam will collapse, share prices will rise significantly and the "bad guys" will receive "visits" by serious people.
(0)
(0)
